Capital Velocity: Five Government Initiatives

Below are five government-initiated actions designed to raise the velocity of capital — that is, how fast money moves from public appropriations and private commitments into real projects, revenues, and reinvestable returns. Each initiative is framed for immediate policy use, highlights public- and private-sector spillovers, and includes practical design features, KPIs, and safeguards. Where relevant, we reference the ASPI Critical Technology Tracker policy recommendations (tax, co-investment, hubs, visas, friend-shoring) that support these directions.

Objective: Shorten the time it takes for dollars to turn into deployed solutions, booked revenues, and follow-on rounds — particularly in AI/software and enabling technologies.

Levers: Procurement speed; co-investment and tax accelerators; cash-flow reform (SR&ED); commercialization hubs; talent & allied R&D mobility.

Expected gains:

• Direct: Faster award-to-deployment cycles; earlier revenue and hiring; larger, quicker private follow-on rounds; higher utilization of IP and public R&D.
• Indirect: Better valuations; higher domestic retention; deeper local supply chains; stronger allied partnerships.

1) 90-Day "Innovation Procurement Fast Lane" (IPFL)

What it is. A standardized, challenge-based federal procurement track that moves from problem statement to pilot award in ≤90 days (target), with phased, milestone-based contracts and pre-negotiated IP/licensing clauses. It expands and systematizes the current challenge programs into a whole-of-government, AI-centric fast lane. Departments pre-commit micro-budgets and use a common commercial template administered by PSPC/TBS; DND/CSC projects can run in parallel tracks. Defense-style "pull" programs (DARPA-like teaming and rapid awards) are specifically encouraged to accelerate commercialization. (ASPI highlights the role of defense departments and DARPA-like models to pull research to market and drive commercialization partnerships.)

How it increases capital velocity.

• Converts appropriations into contracts, not grants, in a fixed window; pays on delivered milestones, improving startup cash cycles.
• Produces reference customers quickly, unlocking private capital and enterprise sales.

Public benefits. Faster access to domestic solutions; measurable delivery against policy outcomes; increased competition and value for money.

Private spillovers. Early revenue; de-risked validation; lower customer acquisition cycle; stronger leverage for growth rounds.

Design features.

• Templates: One set of terms for IP, data, security, and privacy across departments.
• Caps: Pilot contracts up to $1–3M; option to scale without re-competition if milestones met.
• Interoperability: Cloud/AI safety guardrails embedded.
• Sandboxes: Regulatory sandboxes paired with pilots for health/finance/public safety.

KPIs. Award cycle time (median ≤90 days), time to first payment (≤30 days after milestone), # pilots to scaled adoption (≥25%), private $ mobilized per public $ (≥1.5x).

Safeguards. Independent challenge panels; open calls; conflict-of-interest controls; post-award transparency.

2) Automatic 40% Public Co-Investment for Growth Rounds ("Scale-Up Speed Fund")

What it is. A standing, rules-based co-investment facility (managed by CIC/BDC) that automatically matches up to 40% of qualified equity rounds (e.g., Series A–C) for Canadian-headquartered firms in AI/software and critical-tech adjacencies at closing — no separate application timeline. The fund mirrors ASPI's recommendation for proportional public matching to crowd in private capital and counter "Dutch disease" capital diversion.

How it increases capital velocity.

• Closes rounds faster (fewer investor herding delays).
• Reduces time founders spend fundraising, reallocating time to building.
• Creates immediate follow-on capacity for high-performers.

Public benefits. More Canadian IP retained; higher tax base from scaled firms; improved ROI from earlier public R&D.

Private spillovers. Larger rounds, better valuation step-ups, earlier hiring, faster go-to-market. LPs see improved deal certainty.

Design features.

• Qualification: Canadian HQ & significant operations; clear use-of-proceeds (productization, sales scale, compute).
• Pricing: Public tranche follows lead investor terms; pari passu governance.
• Limits: Per-round and lifetime caps; anti-flip provisions; claw-backs for relocation of core IP.
• Speed: Approval by eligibility rules; legal close synchronized with lead investor.

KPIs. Median round close time (days); private/public leverage; % rounds with Canadian lead investors; % firms reaching next stage in 12–18 months.

Safeguards. Independent investment committee; concentration limits; ex-post performance audits.

3) Growth Equity Tax Accelerator (GETA) for Domestic LPs & Corporates

What it is. A time-bound tax package that directs domestic capital into Canadian growth rounds and funds:

• Capital gains deferral or partial exclusion for individuals and tax credits for corporates that commit capital to qualified Canadian tech funds or growth rounds for a minimum hold (e.g., 5–7 years).
• Immediate loss pass-through and carryback to reduce downside risk; reinvestment windows to recycle proceeds quickly. ASPI explicitly recommends favourable taxation to divert private capital toward venture and scale-up.

How it increases capital velocity.

• Pulls "sidelined" domestic capital (pensions, corporates, high-net-worth) into tech faster and at scale.
• Accelerates fund closes and shortens time between fund vintages, speeding capital deployment.

Public benefits. Larger domestic investor base; tax receipts from higher corporate growth; better recycling of Canadian gains into new vintages.

Private spillovers. Reduced cost of capital; more Canadian lead investors (less forced Delaware flips); stronger local syndicates.

Design features.

• Eligibility: Canadian-managed funds ≥70% domestic tech exposure; Canadian-controlled investees.
• Sunset/Review: 5–7 year window with mid-term evaluation.
• Transparency: Public registry of qualifying funds/rounds.

KPIs. Domestic share of LP commitments; time to fund close; ratio of Canadian to foreign lead investors; number and size of later-stage rounds.

Safeguards. Anti-avoidance rules; limits on related-party transactions; independent certification.

4) Real-Time SR&ED ("File-and-Flow") + AI/Compute Credits

What it is. Convert SR&ED from an annual tax event into monthly, automated advances against verified R&D payroll and eligible cloud/compute spend (particularly for AI training/inference), reconciled at year-end. This is a cash-flow reform, not a subsidy increase. It complements ASPI's call to boost commercialization by building targeted mechanisms and ensuring stable long-term research investment translates into on-shore outcomes.

How it increases capital velocity.

• Pulls future SR&ED cash forward into the current month, shrinking the working-capital gap and letting firms hire and ship earlier.
• Reduces reliance on expensive bridge financing and SR&ED factoring.

Public benefits. Higher R&D intensity and continuity; cleaner audit trail from digital payroll and telemetry; improved survival and scale of recipients.

Private spillovers. Faster iteration cycles; earlier market tests; lower dilution (less need for survival capital).

Design features.

• Eligibility: Real-time payroll feed (CRA/ROE-integrated), CRA pre-clearance of cost categories, randomized post-payment audits.
• Compute Credits: A capped, tradable SR&ED sub-credit for AI compute (public cloud and Canadian HPC partners), with safety/compliance guardrails.
• Interlock: Recipients prioritized for IPFL pilots and Speed Fund co-investment if milestones met.

KPIs. Average days from R&D spend to reimbursement (≤30); R&D headcount growth; ratio of SR&ED to private R&D dollars; rate of successful product releases per year.

Safeguards. Strict telemetry and cost tagging; claw-backs for misreporting; blacklisting for abuse; third-party attestation.

5) Frontier Talent & Allied R&D Velocity Package

What it is. A combined talent + allied-R&D instrument to compress team-building and lab-launch timelines:

• 10-day "Frontier Tech Visa" for AI/quantum/cyber/semiconductor talent and founders, with immediate open-work authorization for spouses.
• Allied R&D friend-shoring grants: matching support when firms from trusted allies site R&D/engineering in Canada alongside Canadian startups. ASPI advocates technology visas and friend-shoring of R&D among allies to build collective capacity and speed commercialization.

How it increases capital velocity.

• Reduces time capital sits idle while firms recruit critical talent; speeds lab and product ramp.
• Attracts co-investment from allied corporates that co-locate teams and equipment in Canada.

Public benefits. Larger domestic knowledge base; faster diffusion into public missions (health, climate, defense); stronger supply-chain security.

Private spillovers. Faster hiring; quicker stand-up of engineering pods; shared infrastructure access; cross-border customer introductions.

Design features.

• Priority skills list (AI safety & reliability, distributed systems, applied cryptography, quantum algorithms).
• Reciprocity: Visa reciprocity pilots with UK/Australia/EU tech programs; joint lab MOUs.
• Security: Proportionate screening where national-security risk exists; clear entity lists (aligns with ASPI's visa-screening posture).

KPIs. Time-to-hire (work permit issuance), number of frontier visas issued, # of allied labs established, private co-investment per $ of friend-shoring grant.

Safeguards. Compliance checks; sectoral caps; data residency and IP-ownership conditions.

Cross-cutting governance, sequencing, and communications

• Lead & coordination. ISED (policy), CIC/BDC (investment programs), PSPC/TBS (procurement), CRA (SR&ED), IRCC (visas), DND & SSC (defense/pan-gov cloud/HPC).
• Sequencing (first 12 months).
  1. Stand up IPFL templates and fund pilot envelopes; launch File-and-Flow SR&ED for payroll.
  2. Legislate Scale-Up Speed Fund rules; publish GETA guidance; open registry of qualifying funds.
  3. Launch Frontier Tech Visa with a UK/Australia reciprocity pilot; announce first friend-shored joint labs.
• Commercialization hubs as the backbone. Co-locate IPFL challenges, Speed Fund calls, and SR&ED support inside a national network of public-private commercialization hubs for AI/quantum/cyber, as recommended by ASPI, to keep the pipeline moving from lab to market.

What benefits will these generate?

1) Faster conversion of budgets to impact.

• Award-to-deployment cycles collapse from 12–18 months to a targeted ≤90 days in key use-cases (IPFL), delivering earlier public-service benefits (health triage, fraud analytics, cyber defense) and earlier private revenue.

2) Larger, earlier private rounds and less time fundraising.

• Automatic public matching raises deal certainty and accelerates closings; founders spend more time building, not pitching. (ASPI: proportional public matching to stimulate VC and counter resource-cycle capital crowd-out.)

3) More domestic capital flowing into tech.

• GETA steers corporate and household savings into growth equity; fund closes speed up; a thicker domestic investor base reduces reliance on relocation or foreign control to raise scale capital. (ASPI: favourable tax for venture/scale-up.)

4) Continuous R&D momentum and shorter build cycles.

• Real-time SR&ED stabilizes cash flow and shortens iteration cycles; compute credits ensure capital is spent on product, not interest or SR&ED factoring fees. (ASPI underscores the need for stable, targeted mechanisms to drive commercialization.)

5) Faster team formation and allied infrastructure onshore.

• Frontier visas and friend-shoring compress hiring and lab launch timelines, increase co-investment, and strengthen allied supply chains and know-how exchange — further accelerating deployment speed. (ASPI calls for technology visas and friend-shored R&D across trusted partners.)

6) System-level second-order effects.

• Earlier revenues improve valuation step-ups, which raise the pace of reinvestment by founders and LPs into new vintages (virtuous cycle).
• Government as first customer de-risks adoption for private buyers, increasing demand velocity and shortening enterprise sales cycles.
• Co-located commercialization hubs reduce transaction costs (legal, compliance, security reviews), increasing the throughput of investable projects.

How we'll know it's working (dashboard for Cabinet)

• Cycle times: median days from call to contract (IPFL); from term sheet to close (Speed Fund); from R&D payroll to SR&ED advance.
• Leverage: private $ per public $ (Speed Fund; friend-shoring labs).
• Domestic share: Canadian LP share of fund commitments (GETA); Canadian leads in rounds.
• Scale-up pipeline: # firms crossing $10M / $50M ARR; % pilots that scale to production.
• Talent velocity: time-to-permit; # frontier visas; hires per visa; % retention at 24 months.

Final note

These five initiatives are mutually reinforcing: IPFL creates fast revenue and validation; the Speed Fund and GETA close rounds quickly; File-and-Flow SR&ED keeps teams shipping between raises; Frontier Talent & friend-shoring compress ramp times and pull allied assets onshore; and public-private commercialization hubs tie it together as a continuously moving pipeline from lab to market.